Instrument | ||||
---|---|---|---|---|
05/03/2024 | CH0359145411 | Notice to Investors of JB Actively Managed Certificate on the DW Global Resource Efficiency Index Valor / ISIN / Symbol 35914541 / CH0359145411 / DAFZJB | Corporate Action | |
05/03/2024 | CH0328482945 | Notice to Investors of JB Actively Managed Certificate on the DW Global Disruptive Innovation Index Valor / ISIN / Symbol 32848294 / CH0328482945 / DADHJB | Corporate Action | |
21/02/2024 | CH0591047359 | Notice to Investors of Long Mini Future on Flughafen Zuerich AG Valor / ISIN / Symbol 59104735 / CH0591047359 / LFHAJB | Corporate Action | |
19/02/2024 | CH1145181199 | Notice to Investors of JB Tracker Certificate on the European High Dividend Stocks Valor / ISIN / Symbol 114518119 / CH1145181199 / DALVJB | Corporate Action | |
28/12/2023 | CH1145180928 | Notice to Investors of JB Tracker Certificate on the Japan Dividend Basket 2023 Valor / ISIN / Symbol 114518092 / CH1145180928 / DAFBJB | Corporate Action | |
07/11/2023 | CH0359145411 | Notice to Investors of JB Actively Managed Certificate on the DW Global Resource Efficiency Index Valor / ISIN / Symbol 35914541 / CH0359145411 / DAFZJB | Corporate Action | |
04/10/2023 | CH1284848822 | Notice to Investors of 6.00% p.a. JB Callable Barrier Reverse Convertible (80%) on Novartis AG Valor / ISIN / Symbol 128484882 / CH1284848822 / SAEIJB | Corporate Action | |
04/10/2023 | CH1282670574 | Notice to Investors of 9.50% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267057 / CH1282670574 / MANHJB | Corporate Action | |
04/10/2023 | CH1282670566 | Notice to Investors of 8.00% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267056 / CH1282670566 / MANGJB | Corporate Action | |
04/10/2023 | CH1282670558 | Notice to Investors of 6.50% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267055 / CH1282670558 / MANEJB | Corporate Action | |
04/10/2023 | CH1276583890 | Notice to Investors of 6.65% p.a. JB Barrier Reverse Convertible (85%) on Novartis AG Valor / ISIN / Symbol 127658389 / CH1276583890 / SBPMJB | Corporate Action | |
04/10/2023 | CH1259713324 | Notice to Investors of Call Warrants on Novartis Inc Valor / ISIN / Symbol 125971332 / CH1259713324 / NOVQJB | Corporate Action | |
04/10/2023 | CH1255584349 | Notice to Investors of JB Capped Bonus Certificate on Novartis AG Valor / ISIN / Symbol 125558434 / CH1255584349 / SALWJB | Corporate Action | |
04/10/2023 | CH1255577988 | Notice to Investors of 7.00% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Lonza Group AG, Novartis AG, Roche Holding AG Valor / ISIN / Symbol 125557798 / CH1255577988 / MBJEJB | Corporate Action | |
04/10/2023 | CH1250039281 | Notice to Investors of JB Bonus Certificate on Novartis AG Valor / ISIN / Symbol 125003928 / CH1250039281 / SBOJJB | Corporate Action | |
04/10/2023 | CH1250039158 | Notice to Investors of 6.40% p.a. JB Barrier Reverse Convertible (85%) on Novartis AG Valor / ISIN / Symbol 125003915 / CH1250039158 / SBNWJB | Corporate Action | |
04/10/2023 | CH1250038531 | Notice to Investors of 7.50% p.a. JB Barrier Reverse Convertible (90%) on Novartis AG Valor / ISIN / Symbol 125003853 / CH1250038531 / SBNFJB | Corporate Action | |
04/10/2023 | CH1243066656 | Notice to Investors of JB 1Y CHF 98% Capital Protection Note with Participation on Nestle SA, Novartis AG, Roche Holding AG Valor / ISIN / Symbol 124306665 / CH1243066656 / MBHSJB | Corporate Action | |
04/10/2023 | CH1239729184 | Notice to Investors of JB Bonus Certificate on Novartis AG Valor / ISIN / Symbol 123972918 / CH1239729184 / SBKEJB | Corporate Action | |
04/10/2023 | CH1229751057 | Notice to Investors of 6.50% p.a. JB Callable Multi Barrier Reverse Convertible (60%) on Nestle SA, Roche Holding AG, Novartis AG Valor / ISIN / Symbol 122975105 / CH1229751057 / MAZHJB | Corporate Action |